The accompanying table presents an updated version of the ETFI Highly Defensive PerformIdex, which is expanded to 40 companies with market caps of at least $10B from the industry groups listed below. This defensive growth index is heavily weighted in consumer staples and healthcare and is now structured to include companies based in Europe, in addition to the United States and Canada.
Compared to the previous version, this index has a lower beta and higher average market cap and adds European companie
The accompanying table presents the ETFI Highly Defensive PerformIdex, which is structured as a market cap weighted, defensive growth index of 30 companies based in either the United States or Canada with the largest market capitalizations from each industry group (A-J) as specified below:
(A) Grocery Stores (1) (B) Consumer Staples (10) – Non-Food (2), Food (4), Tobacco (1), Alcoholic Beverages (1), and Non-Alcoholic Beverages (2) (C) Health Benefit Providers (3) – Managed Healthcare (1), Supplemental Health (1), and
CVS Caremark Corp. (CVS) is a pharmacy benefit management company that also operates retail pharmaceutical stores in the <st1:country-region w:st="on"> <st1:place w:st="on"> United States </st1:place> </st1:country-region> . It has over 6000 retail drugstores in the country. <o:p> </o:p>
There is a lot of good stuff happening at CVS, which is why its stock has been faring well. Its purchase of Caremark has been handled wonderfully and contributed to an 84% increase in first-quarter profits. Revenues also jumped 61%. The pharmacy benefit management business is re
With the last days beatings the stock sells for only 15 times next years earnings, in line with its long term growth rate. I think that is just too cheap, especially when compared to its peers that sell for closer to 20 times
The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table includes companies with market caps over $250M which are involved in the following two segments of the healthcare sector with the common theme of reducing healthcare costs and insurance premiums for consumers, employers, and third-party payers such as the government (through Medicare recipients) and insurance companies.
Generic Healthcare Products: This category includes generic prescription and over-the-counter drug products, led by Teva Pharma (TEVA) and Perrigo (PRGO), respectively. The
The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table includes companies with market caps over $250M which are involved in the following two segments of the healthcare sector with the common theme of reducing healthcare costs and insurance premiums for consumers, employers, and third-party payers such as the government (through Medicare recipients) and insurance companies.
Generic Healthcare Products: This category includes generic prescription and over-the-counter drug products, led by Teva Pharma (TEVA) and Perrigo (PRGO), respectively. The
The accompanying table includes an updated version of the ETFI Highly Defensive PerformIdex of 40 companies based in the U.S., Canada, and Europe with market caps over $10B, which are the leaders by market cap in their defensive industry groups. The updates include removing retail exposure at CVS Caremark (CVS) and Tesco (TSCDY) in favor of keeping Wal-Mart (WMT) as the major beneficiary of a trade-down effect and mass merchant discounter, which integrates groceries, pharmacy, everyday clothing, consumer electronics, auto services, and household products in its stores at low prices.
The accompanying table provides statistics and the top seven companies by market cap for the ETFI Health Benefit Providers Index & short ETF proposal of 33 companies with market caps over $100M, which includes all types of pharmacy services (retail, mail order, institutional), pharmacy benefit managers, managed care companies, health insurers, and supplemental health insurance. The 25 lowest rated companies in the index have lost nearly half of their market value in the past year, underperforming the Healthcare Sector SPDR (XLV), iShares Dow Jones U.S. Healthcare Providers (IHF), and the S&...
CVS (CVS) Caremark today announced that it has completed its acquisition of Longs Drug Stores Corporation. The acquisition provides CVS Caremark with Longs’ 521 retail drugstores in California, Hawaii, Nevada and Arizona as well as its Rx America subsidiary, which offers pharmacy benefits management ("PBM") services to over 8 million members and prescription drug plan benefits to approximately 450,000 Medicare beneficiaries.
No mention of any closing adjustments or if they still view the acquisition the same way. Just full speed ahead. Meanwhile other retailers and drug stores are experienci...
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.
